On Monday, November 9, Pfizer CEO Albert Burla sold 62% of his shares in the pharmaceutical company. This was reported by Markers Insider, citing documents from the US Securities and Exchange Commission (SEC). On the same day, Pfizer and BioNTech announced that their experimental COVID-19 vaccine had been successfully tested. Albert Burla sold 132,508 shares […]